Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Aronson

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Thrombosis Research|April 1, 1980
Some properties of antithrombin-III and its concentration in human plasmaG Murano, L Williams, M Miller-Andersson, et al.
Thrombosis Et Diathesis Haemorrhagica|June 30, 1975
Potentially thrombogenic materials in factor IX concentratesH S Kingdon, R L Lundblad, J J Veltkamp, et al.
Thrombosis Research|February 1, 1977
The purification of human acarboxy prothrombin. Characterization of its derivatives after thrombin cleavageM C Guillin, D L Aronson, A Bezeaud, et al.
Thrombosis Et Diathesis Haemorrhagica|November 15, 1975
Proceedings: The isolation of prothrombin fragments from plasma clotted with Russell viper venom (RVV)D L Aronson, L Stevan, A P Ball, et al.
Thrombosis Et Diathesis Haemorrhagica|November 15, 1975
Proceedings: Purification and characterization of activation fragments F1 and F2 from human prothrombinA P Ball, J Fenton, D L Aronson, et al.
The Journal of Clinical Investigation|December 1, 1977
Generation of the combined prothrombin activation peptide (F1-2) during the clotting of blood and plasmaD L Aronson, L Stevan, A P Ball, et al.
American Journal of Hematology|February 3, 2004
Clinical usefulness of a functional assay for the von Willebrand factor cleaving protease (ADAMTS 13) and its inhibitor in a patient with thrombotic thrombocytopenic purpuraM E Rick, H Austin, S F Leitman, et al.
Thrombosis Research|December 1, 1975
Prothrombin profragment-1 optical rotatory dispersion and circular dichroismD A Gabriel, D J Schaefer, H R Roberts, et al.
Thrombosis Research|October 15, 1980
Human prothrombin fragments F1 (alpha beta) and F2: preparation and characterization of structural and biological propertiesD L Aronson, A P Ball, R B Franza, et al.
The Journal of Laboratory and Clinical Medicine|August 1, 1980
Contact-activated factors: contaminants of immunoglobulins preparations with coagulant and vasoactive propertiesB M Alving, D L Tankersley, B L Mason, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Thrombosis Research|April 1, 1980
Some properties of antithrombin-III and its concentration in human plasmaG Murano, L Williams, M Miller-Andersson, et al.
Thrombosis Et Diathesis Haemorrhagica|June 30, 1975
Potentially thrombogenic materials in factor IX concentratesH S Kingdon, R L Lundblad, J J Veltkamp, et al.
Thrombosis Research|February 1, 1977
The purification of human acarboxy prothrombin. Characterization of its derivatives after thrombin cleavageM C Guillin, D L Aronson, A Bezeaud, et al.
Thrombosis Et Diathesis Haemorrhagica|November 15, 1975
Proceedings: The isolation of prothrombin fragments from plasma clotted with Russell viper venom (RVV)D L Aronson, L Stevan, A P Ball, et al.
Thrombosis Et Diathesis Haemorrhagica|November 15, 1975
Proceedings: Purification and characterization of activation fragments F1 and F2 from human prothrombinA P Ball, J Fenton, D L Aronson, et al.
The Journal of Clinical Investigation|December 1, 1977
Generation of the combined prothrombin activation peptide (F1-2) during the clotting of blood and plasmaD L Aronson, L Stevan, A P Ball, et al.
American Journal of Hematology|February 3, 2004
Clinical usefulness of a functional assay for the von Willebrand factor cleaving protease (ADAMTS 13) and its inhibitor in a patient with thrombotic thrombocytopenic purpuraM E Rick, H Austin, S F Leitman, et al.
Thrombosis Research|December 1, 1975
Prothrombin profragment-1 optical rotatory dispersion and circular dichroismD A Gabriel, D J Schaefer, H R Roberts, et al.
Thrombosis Research|October 15, 1980
Human prothrombin fragments F1 (alpha beta) and F2: preparation and characterization of structural and biological propertiesD L Aronson, A P Ball, R B Franza, et al.
The Journal of Laboratory and Clinical Medicine|August 1, 1980
Contact-activated factors: contaminants of immunoglobulins preparations with coagulant and vasoactive propertiesB M Alving, D L Tankersley, B L Mason, et al.
Pageof 7